Patented Innovations Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatment of Parkinsons disease. US10787669B2. Partners Innovation Dopaminergic neurons differentiated from pluripotent stem cells and uses thereof. US9968637B2. Partners Innovation Methods for promoting neurite outgrowth and survival of dopaminergic neurons. AU2006311828B2. Partners Innovation Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseases. US8153422B2. Partners Innovation Glucocerebrosidase gene therapy for Parkinson's disease. US20180147300A1. Partners Innovation Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson’s disease. US9840710B2. Partners Innovation G-substrate for the treatment and prevention of Parkinson's disease. US8545834B2. Partners Innovation Methods for the diagnosis and treatment of Parkinson's disease. W2011090947A2. Partners Innovation RAB3B for treatment and prevention of Parkinson's disease. US8586558B2. Partners Innovation Method of gene delivery to post-mitotic cells. WO1993003743A1. Partners Innovation
